CDO1 and breast cancer: Compared with the control cells, significant demethylation of the CDO1 promoter, accompanied by upregulated CDO1 mRNA and protein levels, was observed in the CRISPR‐treated BC cells (Figure 4D–F, Supporting Information Figure S7).